Skip to main content Skip to main menu
UF Health University of Florida

College of Pharmacy

UNIVERSITY of FLORIDA

APPLY TO PHARM.D. PROGRAM
Juan M Hincapie-Castillo

Juan M Hincapie-Castillo, Pharm.D., M.S., Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-5526
Business Email: j.hincapie@ufl.edu
CV: View Curriculum Vitae

About Juan M Hincapie-Castillo

Juan M. Hincapie-Castillo, Pharm.D, M.S., Ph.D., joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2019. He is a graduate from the University of Florida College of Pharmacy where he received the degrees of Doctor of Pharmacy (2013), Master of Science in Pharmaceutical Sciences (2017), and Ph.D. with a concentration in pharmacoepidemiology (2019). He is the recipient of the 2020 New Investigator Award from the American Association of Colleges of Pharmacy and the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology (ISPE). His research interests include the study of drug utilization and safety in the area of pain management, the evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and the assessment of patient safety and quality for inpatient pain management. He is the current chair of the Latin American Regional Interest Group for ISPE, and he is a consultant for the FDA’s Drug Safety and Risk Management Advisory Committee.

Related Links:
Google Scholar Profile
My NCBI Bibliography
Twitter

Accomplishments

New Investigator Award
2020 · American Association of Colleges of Pharmacy
Keynote Speaker – Doctoral & Master’s Commencement Summer 2020
2020 · University of Florida College of Pharmacy
Faculty Role Model Award
2020 · Comprehensive Cancer Research Training Opportunities for Outstanding Leaders (ReTOOL) Program
Emerging Leader Award
2020 · International Society for Pharmacoepidemiology
Best Reviewer Recognition in 2018
2019 · Pharmacoepidemiology and Drug Safety (Journal)

Research Profile

Drug utilization and safety in pain management, evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and assessment of patient safety and quality for inpatient pain management.

Open Researcher and Contributor ID (ORCID)

0000-0002-6945-2713

Areas of Interest
  • Legal Epidemiology
  • Pain Management
  • Pharmacoepidemiology
  • health services research

Publications

2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open. 3(2) [DOI] 10.1001/jamanetworkopen.2020.0234. [PMID] 32108887.
View on: PubMed Publisher’s Site
2020
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
BMJ quality & safety. 29(8):636-644 [DOI] 10.1136/bmjqs-2019-010098. [PMID] 31649165.
View on: PubMed Publisher’s Site
2020
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA. [DOI] 10.1016/j.japh.2020.09.013. [PMID] 33127312.
View on: PubMed Publisher’s Site
2020
Impact of Opioid Restrictions During a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization
Pain Medicine. [DOI] https://doi.org/10.1093/pm/pnaa211.
View on: Publisher’s Site
2020
Impact of Opioid Restrictions During a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization.
Pain medicine (Malden, Mass.). [DOI] 10.1093/pm/pnaa211. [PMID] 32875327.
View on: PubMed Publisher’s Site
2020
Purchasing Drugs Abroad Among U.S. Cancer Survivors: Analysis of the National Health Interview Survey, 2011-2018.
American journal of preventive medicine. [DOI] 10.1016/j.amepre.2020.10.017. [PMID] 33358718.
View on: PubMed Publisher’s Site
2020
Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
JAMA network open. 3(6) [DOI] 10.1001/jamanetworkopen.2020.8968. [PMID] 32579194.
View on: PubMed Publisher’s Site
2020
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain. [DOI] 10.1016/j.jpain.2020.09.002. [PMID] 33031943.
View on: PubMed Publisher’s Site
2019
Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(14):1059-1070 [DOI] 10.1093/ajhp/zxz100. [PMID] 31185072.
View on: PubMed Publisher’s Site
2018
Clinical utility and perils of prescription drug monitoring program-based alert systems.
Pain. 159(4):804-805 [DOI] 10.1097/j.pain.0000000000001157. [PMID] 29557901.
View on: PubMed Publisher’s Site
2018
Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999-2010.
Psychiatric services (Washington, D.C.). 69(8):919-926 [DOI] 10.1176/appi.ps.201700260. [PMID] 29879872.
View on: PubMed Publisher’s Site
2017
Bariatric Surgery and Risk for Perinatal Complications.
JAMA surgery. 152(6):607-608 [DOI] 10.1001/jamasurg.2017.0113. [PMID] 28329328.
View on: PubMed Publisher’s Site
2017
Consistency of psychotropic drug-drug interactions listed in drug monographs.
Journal of the American Pharmacists Association : JAPhA. 57(6):698-703.e2 [DOI] 10.1016/j.japh.2017.07.008. [PMID] 28844584.
View on: PubMed Publisher’s Site
2017
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(23):1970-1984 [DOI] 10.2146/ajhp160995. [PMID] 29167139.
View on: PubMed Publisher’s Site
2017
Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events
American Journal of Health-System Pharmacy. 74(23):1970-1984
2017
Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study.
Journal of drug assessment. 6(1):1-5 [DOI] 10.1080/21556660.2016.1278545. [PMID] 28265482.
View on: PubMed Publisher’s Site
2017
Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999-2010.
Psychiatric services (Washington, D.C.). 68(11):1120-1126 [DOI] 10.1176/appi.ps.201600511. [PMID] 28669287.
View on: PubMed Publisher’s Site
2017
Use of lithium in patients with unipolar depression.
The lancet. Psychiatry. 4(9):662-663 [DOI] 10.1016/S2215-0366(17)30317-6. [PMID] 28853406.
View on: PubMed Publisher’s Site
2017
Acute Kidney Injury Risk Associated With Piperacillin/Tazobactam Compared With Cefepime During Vancomycin Therapy in Hospitalised Patients: a Cohort Study Stratified By Baseline Kidney Function
International Journal of Antimicrobial Agents. 50(1):63-67 [DOI] 10.1016/j.ijantimicag.2017.02.023.
View on: Publisher’s Site
2014
Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain.
P & T : a peer-reviewed journal for formulary management. 39(6):427-35 [PMID] 25050056.
View on: PubMed
2012
Ototopical neomycin exposure in children with nonintact tympanic membranes.
The Laryngoscope. 122(11):2529-32 [DOI] 10.1002/lary.23554. [PMID] 22965584.
View on: PubMed Publisher’s Site

Grants

Jan 2020 ACTIVE
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Principal Investigator
Funding: AMER ASSO OF COL OF PHARMACY
Sep 2018 ACTIVE
University of Florida Resource Center for Minority Aging Research
Role: Project Manager
Funding: NATL INST OF HLTH NIA

Education

Ph.D.
2019 · University of Florida
M.S.
2017 · University of Florida
Pharm.D.
2013 · University of Florida

Teaching Profile

Courses Taught
2020-2021
PHA7979 Advanced Research
2020-2021
PHA6268 Pharmacoepidemiology and Patient Safety
2020-2021
PHA6910 Supervised Research
2020-2021
PHA7980 Research for Doctoral Dissertation
2019-2021
PHA5244 Prin Evid Based Prac
2020-2021
PHA6935 Selected Topics in Pharmacy
2020-2021
PHA6971 Research for Master’s Thesis
2020
PHA5945 Leadership for International Pharmacy Outreach Experience
2020
PHA5706L Intl Outreach Exper
2018-2019
PHA5226C Pt Safety and Quality
2014-2015
PHA5742C Pro Commun Pharm Prac
2015
PHA5737 Drugs and Society
2014
PHA5226 Evidence-Base Pharmcy
2021
PHA6940 Supervised Teaching
2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021
PHA6937 Topics in Pharmaceutical Administration

Contact Details

Phones:
Business:
(352) 273-5526
Emails:
Business:
j.hincapie@ufl.edu

Recent news

Dr. Juan Hincapie-Castillo appointed as FDA committee consultant

Dr. Hincapie-Castillo has been appointed as a consultant to the FDA’s Drug Safety and Risk Management Advisory Committee.

Dr. Juan Hincapie-Castillo receives the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology

The Emerging Leader Award recognizes ISPE members that have shown early in their careers the potential for leadership and have already made significant contributions to the society.

Dr. Juan Hincapie-Castillo receives AACP New Investigator Award to evaluate opioid use trends via social media

Juan Hincapie-Castillo, Pharm.D., Ph.D., an assistant professor in the UF College of Pharmacy’s department of pharmaceutical outcomes and policy, has received a $10,000 grant from the American Association of Colleges…

New Florida law leads to decline in opioid use, according to UF study

UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.

Read more